Multi-constituent synergism is responsible for anti-inflammatory effect of Azadirachta indica leaf extract

Abstract Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Materia...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical biology Vol. 52; no. 11; pp. 1411 - 1422
Main Authors Umar, Muhammad Ihtisham, Asmawi, Mohd Zaini, Sadikun, Amirin, Abdul Majid, A. M. S., Atangwho, Item Justin, Khadeer Ahamed, Mohamed B., Altaf, Rabia, Ahmad, Ashfaq
Format Journal Article
LanguageEnglish
Published England Informa Healthcare USA, Inc 01.11.2014
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Materials and methods: Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS). Results: All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other. Discussion and conclusion: Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α).
AbstractList Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Materials and methods: Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS). Results: All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other. Discussion and conclusion: Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α).
Abstract Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Materials and methods: Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS). Results: All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other. Discussion and conclusion: Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α).
CONTEXTAzadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures.OBJECTIVETo fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles.MATERIALS AND METHODSPolarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS).RESULTSAll the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other.DISCUSSION AND CONCLUSIONAnti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α).
Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. To fractionate A. indica leaf extracts using bioactivity guided manner for identification of the active anti-inflammatory principles. Polarity-gradient sequential extracts (petroleum ether, chloroform, methanol, and water) of A. indica leaves were screened for their anti-inflammatory potential using the carrageenan-induced rat paw edema model (1 g/kg). The chloroform extract was sequentially fractionated to obtain n-hexane (F-1), n-hexane-chloroform (F-2), and chloroform (F-3) fractions and their inhibitory effect on rat paw edema was evaluated (500 mg/kg). Inhibitory effect of F-2 on granuloma formation, plasma interleukin (IL-1), and tumor necrosis factor (TNF-α) was assessed at the doses of 100, 200, and 400 mg/kg using the cotton pellet assay in rats. Three sub-fractions (SF-1, SF-2, and SF-3) were obtained upon chromatography of F-2, and their inhibitory effect on cyclooxygenase was assessed at 200 µg/mL concentration. The sub-fractions were subjected to gas chromatography-mass spectrometry (GC-MS). All the extracts showed significant anti-inflammatory effect; however, chloroform extract was the most effective against paw edema (53.25% inhibition). The three fractions of chloroform extract showed significant effect, while F-2 being the most potent (51.02%). F-2 demonstrated dose-dependent inhibition of granuloma and cytokines. Interestingly, all the sub-fractions of F-2 inhibited COX-1 and COX-2 with almost equal potential. GC-MS revealed that chemically the sub-fractions were totally different from each other. Anti-inflammatory effect of A. indica is a result of cumulative and synergistic effects of diversified constituents with varying polarities that collectively exert the effect via suppression of cyclo-oxygenases and cytokines (IL-1 and TNF-α).
Author Asmawi, Mohd Zaini
Sadikun, Amirin
Khadeer Ahamed, Mohamed B.
Umar, Muhammad Ihtisham
Ahmad, Ashfaq
Altaf, Rabia
Atangwho, Item Justin
Abdul Majid, A. M. S.
Author_xml – sequence: 1
  givenname: Muhammad Ihtisham
  surname: Umar
  fullname: Umar, Muhammad Ihtisham
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia
– sequence: 2
  givenname: Mohd Zaini
  surname: Asmawi
  fullname: Asmawi, Mohd Zaini
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia
– sequence: 3
  givenname: Amirin
  surname: Sadikun
  fullname: Sadikun, Amirin
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia
– sequence: 4
  givenname: A. M. S.
  surname: Abdul Majid
  fullname: Abdul Majid, A. M. S.
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: EMAN Testing and Research Laboratories, School of Pharmaceutical Sciences, Universiti Sains Malaysia
– sequence: 5
  givenname: Item Justin
  surname: Atangwho
  fullname: Atangwho, Item Justin
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia
– sequence: 6
  givenname: Mohamed B.
  surname: Khadeer Ahamed
  fullname: Khadeer Ahamed, Mohamed B.
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: EMAN Testing and Research Laboratories, School of Pharmaceutical Sciences, Universiti Sains Malaysia
– sequence: 7
  givenname: Rabia
  surname: Altaf
  fullname: Altaf, Rabia
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia
– sequence: 8
  givenname: Ashfaq
  surname: Ahmad
  fullname: Ahmad, Ashfaq
  email: mihtishamu@gmail.com, khadeer.nc@gmail.com, mihtishamu@gmail.com, khadeer.nc@gmail.com
  organization: School of Pharmaceutical Sciences, Universiti Sains Malaysia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25026347$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1v1DAQhiNURD_gHyDkI5csthMnzgVUVRSQirjA2ZrYY9Yrx15sR7D8-nq1LRKXnjzyPPPO6LlszkIM2DSvGd10jE7vWCcl5XTacMr6jZwEZeOz5oKNfd8KxoazWlekPTLnzWXOO0qp6DrxojnngvKh68eLZvd19cW1OoZcXFkxFJIPAdNPlxfiMkmY97XnZo_ExkQgVNoF62FZoMR0IGgt6kKiJdd_wbgEeluAuGCcBuIRLME_pf6Wl81zCz7jq4f3qvlx-_H7zef27tunLzfXd63umSytZB0MSFEMXM7cwCAlaDMhZ1aLWRozS2oM5xMXYMZpstRKIXU_AgzUGuiumren3H2Kv1bMRS0ua_QeAsY1KzYwzqWYBlbR_oTqFHNOaNU-uQXSQTGqjpbVo2V1tKxOluvYm4cN67yg-Tf0qLUCH05ANRXTAr9j8kYVOPiYbIKgXT7GP7ni_X8JWwRfthoSql1cU6gCn77xHogKo3Q
CitedBy_id crossref_primary_10_3389_fphar_2022_890938
crossref_primary_10_2174_1871520620666201005100132
crossref_primary_10_2174_1389201022666210702120956
crossref_primary_10_1007_s13205_021_02745_4
crossref_primary_10_1016_j_jep_2021_114179
crossref_primary_10_1016_j_jtcme_2021_09_003
crossref_primary_10_15446_rfnam_v73n3_80501
crossref_primary_10_2147_CCID_S342227
crossref_primary_10_3390_molecules26113456
crossref_primary_10_3390_molecules27072323
crossref_primary_10_1016_j_envpol_2021_118660
crossref_primary_10_29252_mlj_13_1_21
crossref_primary_10_1038_srep45479
crossref_primary_10_1016_S1875_5364_17_30076_6
crossref_primary_10_3390_molecules21101321
crossref_primary_10_3390_molecules27113536
Cites_doi 10.1016/S0031-9422(00)00456-8
10.1016/S1995-7645(11)60247-2
10.1590/S0102-695X2012005000041
10.3390/molecules17078720
10.2174/0929867033368583
10.1055/s-0029-1185315
10.1016/S0162-3109(99)00132-0
10.1074/jbc.M112.341321
10.1046/j.1365-2672.1998.00324.x
10.1074/jbc.M110.169334
10.1007/s12263-010-0194-6
10.1371/journal.pone.0016999
10.1208/s12248-011-9279-4
10.1016/0022-1759(95)00127-V
10.4103/0974-8490.91028
10.1016/j.jep.2009.07.004
10.1002/ptr.1474
10.1016/j.semcancer.2012.02.008
10.1007/s10787-008-8032-9
10.1055/s-2007-971670
10.1016/j.jep.2003.12.004
10.2174/1568011053174828
ContentType Journal Article
Copyright 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014
Copyright_xml – notice: 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.3109/13880209.2014.895017
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1744-5116
EndPage 1422
ExternalDocumentID 10_3109_13880209_2014_895017
25026347
895017
Genre Original Articles
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
00X
0R~
0YH
123
29O
4.4
53G
5VS
7X7
8FI
8FJ
AALIY
ABDBF
ABPTK
ABUWG
ACGEJ
ACGFS
ADBBV
ADCVX
ADRBQ
ADXPE
AENEX
AEYQI
AFKRA
AFKVX
AJWEG
ALIIL
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARJSQ
AWYRJ
BABNJ
BCNDV
BENPR
BPHCQ
BVXVI
CAG
COF
CS3
CZDIS
DRXRE
DU5
DWTOO
EAL
EAP
EBD
EBS
EJD
EMK
EMOBN
EPL
EPT
EST
ESX
F5P
FYUFA
GROUPED_DOAJ
H13
HYE
HZ~
J.N
KTTOD
M44
M4Z
ML~
O9-
P2P
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
Q~Q
RPM
SV3
TFDNU
TFL
TFW
TUS
UKHRP
V1S
~1N
AAHBH
ALIPV
CCPQU
CGR
CUY
CVF
ECM
EIF
HMCUK
NPM
NUSFT
TDBHL
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c418t-813a6e0e5628b2da688acd9e21fc5b8ddb80dd22925ad799f0f858c47aa60fda3
IEDL.DBID 0YH
ISSN 1388-0209
IngestDate Sat Aug 17 00:01:22 EDT 2024
Fri Aug 23 01:33:53 EDT 2024
Sat Sep 28 08:07:43 EDT 2024
Tue Jun 13 19:57:31 EDT 2023
Wed Jun 21 08:18:34 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords carrageenan assay
TNF-α
interlukin-1
Bioactivity guided fractionation
cotton pellet assay
cyclooxygenase
cytokines
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c418t-813a6e0e5628b2da688acd9e21fc5b8ddb80dd22925ad799f0f858c47aa60fda3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25026347
PQID 1612285961
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_1612285961
crossref_primary_10_3109_13880209_2014_895017
informaworld_taylorfrancis_310_3109_13880209_2014_895017
pubmed_primary_25026347
informahealthcare_journals_10_3109_13880209_2014_895017
PublicationCentury 2000
PublicationDate 20141100
11/1/2014
2014-Nov
2014-11-00
20141101
PublicationDateYYYYMMDD 2014-11-01
PublicationDate_xml – month: 11
  year: 2014
  text: 20141100
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pharmaceutical biology
PublicationTitleAlternate Pharm Biol
PublicationYear 2014
Publisher Informa Healthcare USA, Inc
Taylor & Francis
Publisher_xml – name: Informa Healthcare USA, Inc
– name: Taylor & Francis
References Ahamed MBK (CIT0001) 2009; 75
Mahapatra S (CIT0014) 2011; 13
Koul A (CIT0013) 2009; 17
Namsa ND (CIT0017) 2009; 125
Petrovsky N (CIT0020) 1995; 186
Schumacher M (CIT0025) 2011; 6
Goodman LS (CIT0008) 2001
Phillipson JD (CIT0021) 2001; 56
Jones PJ (CIT0009) 2002; 166
Subapriya R (CIT0027) 2005; 5
Dasgupta T (CIT0005) 2004; 92
Mathur M (CIT0016) 2012; 22
Samud AM (CIT0024) 1999; 43
Ezhilan B (CIT0006) 2012; 4
Manogaran S (CIT0015) 1998; 18
Owoyele BV (CIT0019) 2008; 2
Kaur G (CIT0011) 2004; 18
Kanterman J (CIT0010) 2012; 22
Rasoanaivo P (CIT0023) 2011; 10
Anosike CA (CIT0003) 2012; 5
Takigawa TK (CIT0028) 2011; 6
Thoh M (CIT0030) 2011; 286
Ramos-Nino ME (CIT0022) 1998; 84
Umar MI (CIT0031) 2012; 17
Okpanyi SN (CIT0018) 1981; 41
CIT0007
Alam A (CIT0002) 2012; 287
Biswas K (CIT0004) 2002; 82
References_xml – volume: 56
  start-page: 237
  year: 2001
  ident: CIT0021
  publication-title: Phytochemistry
  doi: 10.1016/S0031-9422(00)00456-8
  contributor:
    fullname: Phillipson JD
– volume: 5
  start-page: 62
  year: 2012
  ident: CIT0003
  publication-title: Asian Pac J Trop Med
  doi: 10.1016/S1995-7645(11)60247-2
  contributor:
    fullname: Anosike CA
– volume: 22
  start-page: 994
  year: 2012
  ident: CIT0016
  publication-title: Braz J Pharmacog
  doi: 10.1590/S0102-695X2012005000041
  contributor:
    fullname: Mathur M
– volume: 17
  start-page: 8720
  year: 2012
  ident: CIT0031
  publication-title: Molecules
  doi: 10.3390/molecules17078720
  contributor:
    fullname: Umar MI
– volume: 2
  start-page: 219
  year: 2008
  ident: CIT0019
  publication-title: J Med Plant Res
  contributor:
    fullname: Owoyele BV
– ident: CIT0007
  doi: 10.2174/0929867033368583
– volume: 75
  start-page: 478
  year: 2009
  ident: CIT0001
  publication-title: Planta Med
  doi: 10.1055/s-0029-1185315
  contributor:
    fullname: Ahamed MBK
– volume: 43
  start-page: 311
  year: 1999
  ident: CIT0024
  publication-title: Immunopharmacology
  doi: 10.1016/S0162-3109(99)00132-0
  contributor:
    fullname: Samud AM
– volume: 287
  start-page: 24844
  year: 2012
  ident: CIT0002
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.341321
  contributor:
    fullname: Alam A
– volume: 84
  start-page: 207
  year: 1998
  ident: CIT0022
  publication-title: J Appl Microbiol
  doi: 10.1046/j.1365-2672.1998.00324.x
  contributor:
    fullname: Ramos-Nino ME
– volume: 286
  start-page: 4690
  year: 2011
  ident: CIT0030
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.169334
  contributor:
    fullname: Thoh M
– volume: 166
  start-page: 1555
  year: 2002
  ident: CIT0009
  publication-title: Can Med Assoc J
  contributor:
    fullname: Jones PJ
– volume: 6
  start-page: 149
  year: 2011
  ident: CIT0025
  publication-title: Genes Nutr
  doi: 10.1007/s12263-010-0194-6
  contributor:
    fullname: Schumacher M
– volume: 6
  start-page: 1
  year: 2011
  ident: CIT0028
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0016999
  contributor:
    fullname: Takigawa TK
– volume: 13
  start-page: 365
  year: 2011
  ident: CIT0014
  publication-title: AAPS J
  doi: 10.1208/s12248-011-9279-4
  contributor:
    fullname: Mahapatra S
– volume: 186
  start-page: 37
  year: 1995
  ident: CIT0020
  publication-title: J Immunol Methods
  doi: 10.1016/0022-1759(95)00127-V
  contributor:
    fullname: Petrovsky N
– volume: 82
  start-page: 1336
  year: 2002
  ident: CIT0004
  publication-title: Curr Sci
  contributor:
    fullname: Biswas K
– volume: 4
  start-page: 11
  year: 2012
  ident: CIT0006
  publication-title: Pharmacog Res
  doi: 10.4103/0974-8490.91028
  contributor:
    fullname: Ezhilan B
– volume: 10
  start-page: 1
  issue: 4
  year: 2011
  ident: CIT0023
  publication-title: Malaria J
  contributor:
    fullname: Rasoanaivo P
– volume-title: Goodman & Gilman's The Pharmacological Basis of Therapeutics
  year: 2001
  ident: CIT0008
  contributor:
    fullname: Goodman LS
– volume: 125
  start-page: 234
  year: 2009
  ident: CIT0017
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2009.07.004
  contributor:
    fullname: Namsa ND
– volume: 18
  start-page: 419
  year: 2004
  ident: CIT0011
  publication-title: Phytother Res
  doi: 10.1002/ptr.1474
  contributor:
    fullname: Kaur G
– volume: 22
  start-page: 307
  year: 2012
  ident: CIT0010
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2012.02.008
  contributor:
    fullname: Kanterman J
– volume: 17
  start-page: 29
  year: 2009
  ident: CIT0013
  publication-title: Inflammopharmacology
  doi: 10.1007/s10787-008-8032-9
  contributor:
    fullname: Koul A
– volume: 41
  start-page: 34
  year: 1981
  ident: CIT0018
  publication-title: Planta Med
  doi: 10.1055/s-2007-971670
  contributor:
    fullname: Okpanyi SN
– volume: 92
  start-page: 23
  year: 2004
  ident: CIT0005
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2003.12.004
  contributor:
    fullname: Dasgupta T
– volume: 18
  start-page: 29
  year: 1998
  ident: CIT0015
  publication-title: Ancient Sci Life
  contributor:
    fullname: Manogaran S
– volume: 5
  start-page: 149
  year: 2005
  ident: CIT0027
  publication-title: Curr Med Chem Anti-Cancer Agents
  doi: 10.2174/1568011053174828
  contributor:
    fullname: Subapriya R
SSID ssj0005335
Score 2.1797829
Snippet Abstract Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective:...
Context: Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. Objective: To...
Azadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures. To fractionate A. indica leaf...
CONTEXTAzadirachta indica A. Juss. (Meliaceaes) leaves have been used traditionally to treat swelling and rheumatism in Indian cultures.OBJECTIVETo fractionate...
SourceID proquest
crossref
pubmed
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 1411
SubjectTerms Animals
Anti-Inflammatory Agents - isolation & purification
Anti-Inflammatory Agents - therapeutic use
Azadirachta
Bioactivity guided fractionation
carrageenan assay
cotton pellet assay
cyclooxygenase
cytokines
Dose-Response Relationship, Drug
Drug Synergism
Edema - blood
Edema - drug therapy
Edema - pathology
Female
Humans
interlukin-1
Male
Plant Extracts - isolation & purification
Plant Extracts - therapeutic use
Plant Leaves
Rats
Rats, Sprague-Dawley
Sheep
TNF-α
Treatment Outcome
Title Multi-constituent synergism is responsible for anti-inflammatory effect of Azadirachta indica leaf extract
URI https://www.tandfonline.com/doi/abs/10.3109/13880209.2014.895017
https://www.ncbi.nlm.nih.gov/pubmed/25026347
https://search.proquest.com/docview/1612285961
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELWAXrggaAssH5WRECcMiZM4zhGholWlIg4gwSkaf4lFsItIOCy_npl4l6VUgMQlkg8TO3njzDie98zYri8xyJRZKirjS5ErZ0UFGV6cMxmkyoEn7vDfU9W_yP9cFpevWPxUVklr6BCFIrpvNU1uMN0JJKRjeZiSgIlMiGaS5ge6KrC3efZNYuZNnp5c9WdFHll3xCZZCDKJ5Ll37_JPcFqeSJdevxRivZEzfT8p7YLTyTJbmmSV_Ci6wQqb88PvbO8sylKP9_n5jGXV7PM9fjYTrB7_YDcdC1fYUSwcwDDEmzFxAgfNHR80_GFaR3vrOY6LIxgDgUNEZ7rrNul5rArho8CPngCjJNjrFjhth1vgtx4CxxhAfKyf7OLk9_lxX0zOYBA2T3UrdJqB8onHNEkb6UBpDdZVXqbBFkYjojpxTspKFuDKqgpJ0IW2eQmgkuAgW2ULw9HQrzMOoUisMhCSwuTaOANoh01dWtAyqB4T05df30epjRqXKARWPQWrJrDqCFaPlf8hVE9mYPOJpX6NY912P0dCPMmEzD4y3ZliXuNEpN0VGPrRI3aIuSKpAaq0x9aiM7w8BuaZUmV5ufH1jjfZIrUiDXKLLbQPj34b86HW_Opc_hlHOgNL
link.rule.ids 315,786,790,27533,27955,27956,59496,59497,61571,61572
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagHOCCynvLy0iop5o6L8c-VohqgbbqYSvByZr4oS5qd1GTHra_npk46fJQQeISKYomTvKNM2N7vs-MvQ01Bpm6yIRpQi1K5Z0wUODB-6aATHkIxB0-PFLTk_LTl2qsJmyHskoaQ8ckFNH_q6lz02T0bj_ElGY3IwWTXBLPJCvfaVNhc7fZncqUhsZf8ut0XeVR9HtskoUgk8Seu_Euv0SnzUG79PS6Eus3PdObs9I-Ou1vsvtDWsn3kh88YLfC4iHbPk661KsdPlvTrNodvs2P14rVq0fsW0_DFW6ZKgcwDvF2RaTAeXvO5y2_GAtpzwLH5-KIxlzgI6I3nfer9DyVhfBl5HtXgGES3GkHnNbDHfCzAJFjECBC1mN2sv9h9n4qhk0YhCsz3QmdFaCCDJgn6Sb3oLQG503Is-iqRiOkWnqf5yavwNfGRBl1pV1ZAygZPRRP2MZiuQjPGIdYSacaiLJqSt34BtAOT3XtQOdRTZgYP779nrQ2LI5RCCw7gmUJLJvAmrD6D4Ts0AXbf1jqn3G0XT87EtNWJmT2N9M3I-YWeyItr8AiLC-xQUwWSQ5QZRP2NDnD9Wtgopmroqy3_r_h1-zudHZ4YA8-Hn1-zu7RlcSJfME2uovL8BKTo6551bv_D2TWBsE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZaKlW9IPpeoK0rVZxwcV6OfURtV9sX2gNI9GRN_BBbwS4i4bD8embiXZa2opV6iRRFEzv5xplxPN9nxt6FGoNMXWTCNKEWpfJOGCjw4H1TQKY8BOIOfz9Qo6Pyy3F1fIvFT2WVNIeOSSii_1bT4D73ca-fYUqzl5GASS6JZpKV77WpsLX77EFlSkM-Ln-MVkUeRb_FJlkIMknkuTvv8ktw2lhIl57cFGL9Jmd6d1LaB6fhBltfZJV8P7nBY3YvTJ-wnXGSpZ7v8sMVy6rd5Tt8vBKsnj9lP3sWrnCzVDiAYYi3c-IETtozPmn5xbKO9jRw7BdHMCYCu4jOdNYv0vNUFcJnke9fAUZJcCcdcFoOd8BPA0SOMYD4WM_Y0fDT4YeRWOzBIFyZ6U7orAAVZMA0STe5B6U1OG9CnkVXNRoR1dL7PDd5Bb42JsqoK-3KGkDJ6KF4ztams2l4yTjESjrVQJRVU-rGN4B2eKprBzqPasDE8uXb8yS1YXGKQmDZJViWwLIJrAGr_0DILkZg-w9LfRtH2_U_R2LayYTM_mb6dom5xYFIqyswDbNLbBBzRVIDVNmAvUjOcPMYmGfmqijrzf9v-A17OP44tN8-H3zdYo_oQmJEbrO17uIyvMLUqGte995_Dbi6Beo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multi-constituent+synergism+is+responsible+for+anti-inflammatory+effect+of+Azadirachta+indica+leaf+extract&rft.jtitle=Pharmaceutical+biology&rft.au=Umar%2C+Muhammad+Ihtisham&rft.au=Asmawi%2C+Mohd+Zaini&rft.au=Sadikun%2C+Amirin&rft.au=Abdul+Majid%2C+A.+M.+S.&rft.date=2014-11-01&rft.pub=Taylor+%26+Francis&rft.issn=1388-0209&rft.eissn=1744-5116&rft.volume=52&rft.issue=11&rft.spage=1411&rft.epage=1422&rft_id=info:doi/10.3109%2F13880209.2014.895017&rft.externalDocID=895017
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-0209&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-0209&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-0209&client=summon